We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vanda Sues FDA for ‘Capricious’ Denial of Fast-Track Status
Vanda Sues FDA for ‘Capricious’ Denial of Fast-Track Status
In an unusual legal action, Vanda Pharmaceuticals is suing the FDA in a federal court for denying a request for Fast-Track designation for its investigational drug tradipitant after a series of failed attempts using other regulatory pathways.